Cancer Genetics Inc (CGIX.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cancer Genetics, Inc completes acquisition of BioServe India


Monday, 18 Aug 2014 12:30am EDT 

Cancer Genetics, Inc:Completes acquisition of BioServe Biotechnologies (India) Pvt. Ltd. 

Latest Developments forCancer Genetics Inc